Cenix BioScience joins NANOTOME consortium, securing grant support from German Federal Ministry of Education and Research (BMBF).
 

Dresden, Germany, November 5, 2007  - Cenix BioScience GmbH today announced that it has joined the German NANOTOME consortium to participate in its project entitled "A platform for the application of laser and multi-photon microscopy for RNAi experimentation" with support from a German Federal Ministry of Education and Research (BMBF) research grant.

The consortium is led by Hannover based Rowiak GmbH, and also includes LaVision BioTec GmbH (Bielefeld), mfd Diagnostics GmbH (Wendelsheim), co.don AG (Teltow), iba Institute for Bioprocessing and Analytical Measurement Techniques (Heiligenstadt), LZH Laser Center (Hannover), as well as the Institute of Biophysics, and the Institute of Quantum Optics of the Leibniz University of Hannover, Germany. The 3-year grant, which includes 233,000 Euro funding for Cenix, will support the development of advanced laser-based experimentation in cultured human cells, including transient permeabilization of cells to introduce RNAi-inducing agents, and diverse other intra-cellular manipulations. Cenix will integrate the newly developed capabilities within its leading range of advanced RNAi research services for target discovery, target validation and drug mode of action analyses.